{"id":"W4416140351","doi":"10.1093/neuonc/noaf201.0557","title":"CTNI-61. A PHASE 2 STUDY OF ERDAFITINIB IN PATIENTS WITH RECURRENT OR PROGRESSIVE IDH-WILD TYPE GLIOMA WITH FGFR-TACC GENE FUSIONS: SAFETY RUN-IN COHORT RESULTS","year":2025,"lang":"en","type":"article","venue":"Neuro-Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cohort; Tolerability; Adverse effect; Glioma; Performance status; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003528807,0.000298,0.0005328579,0.0003608757,0.00008152247,0.00001739419,0.0003899689,0.0002455784,0.00002521477],"category_scores_gemma":[0.0006569367,0.0002172083,0.00003811315,0.001033589,0.0002304014,0.00001048034,0.0003776358,0.0004292085,0.000003632986],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001136766,"about_ca_system_score_gemma":0.0009953458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009292149,"about_ca_topic_score_gemma":0.00132781,"domain_scores_codex":[0.9969718,0.0005672264,0.0006874518,0.0008718021,0.0003751915,0.0005265473],"domain_scores_gemma":[0.9983809,0.0001809248,0.0002813131,0.0006400415,0.0003990233,0.0001177774],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1587179,0.01390917,0.5409762,0.0001157528,0.0002749941,0.0009064554,0.0006862879,0.0001539486,0.2703292,0.00001167374,0.0009521929,0.01296629],"study_design_scores_gemma":[0.09444238,0.147734,0.6213316,0.0004231027,0.0001381526,0.00006409997,0.0007886349,0.0001223922,0.1133812,0.000007888932,0.02078986,0.0007767],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961307,0.0001082163,0.000007259458,0.0001726614,0.0001445559,0.002818949,0.000103104,0.00001441646,0.0005001068],"genre_scores_gemma":[0.9990287,0.00004379148,0.0002360457,0.0000998365,0.00004021867,0.0002295113,0.0002491154,0.00003516784,0.00003760468],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1569479,"threshold_uncertainty_score":0.8857498,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01443492215162411,"score_gpt":0.3330471567387479,"score_spread":0.3186122345871238,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}